Li Fuqiang, Wu Yijun, Chen Liang, Hu Liang, Liu Xiaosun
Thyroid Disease Diagnosis and Treatment Center, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310003, China.
Ann Transl Med. 2019 Jan;7(1):8. doi: 10.21037/atm.2018.12.43.
Papillary thyroid microcarcinoma (PTMC), one specific subtype of papillary thyroid carcinoma (PTC) which measures less than 10 mm in maximum dimension, presents with a high risk of insidious lymph node metastasis escaping from preoperative examinations (cN0). Given the complications of lymph node dissection (LND) and metastasis risk, proper stratification of PTMC for performing prophylactic LND bears great importance.
From June 2015 to December 2017, 338 PTMC patients undergoing thyroidectomy were included in the present study. Potential risk factors, including age, gender, maximal tumor size, etc. were collected and analyzed for association with thyroid lymph node metastasis.
Among the 338 patients, 87 patients (25.7%) presented with right central lymph node metastasis (CLNM) and 28 patients (8.3%) had posterior right recurrent laryngeal nerve lymph node metastasis (PRRLN-LNM). The maximal tumor was prone to occur at the middle part of the lower pole (35.3%) in patients with right CLNM, while the proportion of tumors located in the middle part of the upper pole (17.2%) was highest in PRRLN-LNM patients. Ages younger than 45 years old, male gender, and a tumor size of more than 0.5 cm were correlated independently with right CLNM and PRRLN-LNM. Presence of capsular invasion also had a significant association with the occurrence of PRRLN-LNM.
Ages younger than 45, male gender, and a maximal tumor size larger than 0.5 cm, in addition to capsular invasion, were independent risk factors for stratification of PTMC patients. PTMC patients with these clinical characteristics were suggested to receive prophylactic LND in their initial thyroid surgeries.
甲状腺微小乳头状癌(PTMC)是甲状腺乳头状癌(PTC)的一种特殊亚型,最大径小于10mm,隐匿性淋巴结转移风险高,术前检查难以发现(cN0)。鉴于淋巴结清扫(LND)的并发症和转移风险,对PTMC进行合理分层以实施预防性LND至关重要。
2015年6月至2017年12月,本研究纳入338例行甲状腺切除术的PTMC患者。收集并分析年龄、性别、肿瘤最大径等潜在危险因素与甲状腺淋巴结转移的相关性。
338例患者中,87例(25.7%)出现右侧中央区淋巴结转移(CLNM),28例(8.3%)出现右侧喉返神经后淋巴结转移(PRRLN-LNM)。右侧CLNM患者的最大肿瘤多发生于下极中部(35.3%),而PRRLN-LNM患者中肿瘤位于上极中部的比例最高(17.2%)。年龄小于45岁、男性以及肿瘤大小大于0.5cm与右侧CLNM和PRRLN-LNM独立相关。包膜侵犯的存在也与PRRLN-LNM的发生显著相关。
年龄小于45岁、男性、最大肿瘤大小大于0.5cm以及包膜侵犯是PTMC患者分层的独立危险因素。建议具有这些临床特征的PTMC患者在初次甲状腺手术时接受预防性LND。